The New Chemist’s Podcasting Group — The Path to KOLs: Accelerating First-in-Human in LATAM — Julio G. Martinez-Clark, CEO, bioaccess® w/ Chadwin Hanna, MD-PhD Student (UF) and David Ferguson (Host)

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/5f/b5/07/5fb5076e-ee87-2038-5971-0048ff35b0f8/mza_9409999970994965160.jpg/600x600bb.jpg

Blueprint: Inventing the Future. Catalyzing STEAM Access. Closing the Gap.

Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC

322 episodes

5 days ago

Innovation isn't accidental; it's designed. Welcome to The Blueprint, a show committed to inventing the future and closing the gap between aspiration and achievement. We deconstruct the mechanics of success in modern science to provide access to the insights that matter most. Featuring masterclasses in leadership from icons such as Dr. Robert Langer, Chancellor Gary May, Provost Raheem Beyah, Dr. Todd Golub, and Greg Zuckerman, this is your guide to navigating—and leading—the next era of discovery.

Chemistry

Science

RSS

All content for Blueprint: Inventing the Future. Catalyzing STEAM Access. Closing the Gap. is the property of Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Chemistry

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/7605281/7605281-1754931868444-fb5641afa64cb.jpg

The New Chemist’s Podcasting Group — The Path to KOLs: Accelerating First-in-Human in LATAM — Julio G. Martinez-Clark, CEO, bioaccess® w/ Chadwin Hanna, MD-PhD Student (UF) and David Ferguson (Host)

Blueprint: Inventing the Future. Catalyzing STEAM Access. Closing the Gap.

58 minutes 54 seconds

2 months ago

---

On The Path to KOLs from The New Chemist’s Podcasting Group, hosts David Ferguson and Chadwin Hanna explore how Latin America is becoming a strategic engine for high-quality, cost-effective clinical research.

Julio G. Martinez-Clark—Ambassador of IAOCR/GCSA Americas and CEO of bioaccess®—breaks down how aligning to global competence standards and smarter site activation can compress timelines for First-in-Human and Early Feasibility Studies without compromising quality. He shares lessons from pioneering trials, practical blueprints for building city-level clinical hubs, and pragmatic guidance for innovators entering LATAM markets. The conversation also touches on sustaining regional infrastructure, cross-border collaboration, and the mindset behind his long-running Global Trial Accelerators™ series.

Guest: Julio G. Martinez-Clark, CEO, bioaccess®
Hosts: David Ferguson, BS, MS, Pharm.D. Candidate; Chadwin Hanna, MD Candidate & PhD Student

Please note: The views of this podcast reflect those of my guest(s) and I, and do not constitute medical advice, consultation and suggestions. Please see a board certified and state licensed medical professional.